David Brassat

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

Álvaro Cobo‐Calvo, Anne Ruiz, Élisabeth Maillart et al. · Neurology · 2018 · 532 citations

Life Sciences, Neurology, Neuroscience +17

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

Ludwig Kappos, Giancarlo Comi, Hillel Panitch et al. · Nature Medicine · 2000 · 514 citations

Life Sciences, Immunology, Neurology +17

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kühle, Giulio Disanto, Ruth Dobson et al. · Multiple Sclerosis Journal · 2015 · 296 citations · Full text

Life Sciences, Immunology, Neurology +10

Mapping of Spinocerebellar Ataxia 13 to Chromosome 19q13.3-q13.4 in a Family with Autosomal Dominant Cerebellar Ataxia and Mental Retardation

Alexandra Herman-Bert, Giovanni Stévanin, J C Netter et al. · The American Journal of Human Genetics · 2000 · 159 citations · Full text

Life Sciences, Genetics, Neurology +14

Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects

Luisa Klotz, Melanie Eschborn, Maren Lindner et al. · Science Translational Medicine · 2019 · 143 citations · Full text

Life Sciences, Immunology, Neuroscience +16